The goal of this postdoctoral training program is to train young scientists and promote careers focused on understanding and developing treatments for developmental brain disorders. Multidisciplinary training is planned in scientific disciplines relevant to the study of neurodevelopmental disorders. Thus, 23 training faculty have been selected from 4 departments. They include: 3 MDs, 7 MD/PhDs and 13 PhDs. There are: 12 Professors, 5 Associate Professors and 6 Assistant Professors. There are currently 95 postdoctoral students training in laboratories of the faculty and include 7 MD/PhDs, 11 MDs and 77 PhDs. Dr. John Swann will continue to serve as the Program Director and will be responsible for the day-to-day operation of the program. Drs. Huda Zoghbi and Jeff Noebels will continue to serve as co-directors. Major areas of training include the genetic and molecular basis of neurodevelopmental disorders including but not limited to: Rett syndrome, Angelman syndrome, Fragile X syndrome and Autism. Another concentrated area of training is in epilepsy where the molecular bases of the inherited as well as acquired epilepsies are studied. All labs employ cutting edge biotechnology to create and study relevant animals models of disease in order to not only understand the biological basis for these disorders but to screen potential new therapies that could lead to clinical trials and eventually enter clinical practice. Over the past years of support, 24 postdoctoral students have thus far entered our training program and 8 have accepted faculty positions at major universities. These include 4 MD/PhD child neurologists that have been awarded K08 grants and are now pursuing research careers. Three training tracks are offered. One is for MD/PhDs and MDs with substantial research experience. Another is for less experienced MDs where training is more formal and includes laboratory rotations and graduate courses. PhDs receive substantial training in clinical aspects of neurodevelopmental disorders through dinner discussions, clinical conferences and subspecialty clinics. The opening of the Jan and Dan Duncan Neurological Research Institute (The NRI) is the most recent and dramatic demonstration of the commitment of Texas Children's Hospital and Baylor College of Medicine to the study of the neurobiology of developmental disorders. This training program is now based in the NRI, which promises to become a major center for the study of and training in developmental brain abnormalities. By training outstanding research scientists, we feel new understandings and treatments for the devastating neurological disorders of infants and young children will emerge.
The goal of this postdoctoral training program is to train young scientist so that they can devote their careers to understanding the molecular mechanisms responsible for neurological disorders in children. This training program is a key component of a growing academic/research infrastructure at Baylor College of Medicine devoted to understanding and developing new therapies for devastating neurological disorders of brain development.
|Murphey, Dona K; Herman, Alexander M; Arenkiel, Benjamin R (2014) Dissecting inhibitory brain circuits with genetically-targeted technologies. Front Neural Circuits 8:124|
|Yamamoto, Shinya; Jaiswal, Manish; Charng, Wu-Lin et al. (2014) A drosophila genetic resource of mutants to study mechanisms underlying human genetic diseases. Cell 159:200-14|
|Bomben, Valerie; Holth, Jerrah; Reed, John et al. (2014) Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy. Neurobiol Aging 35:2091-5|
|Klassen, Tara L; Bomben, Valerie C; Patel, Ankita et al. (2014) High-resolution molecular genomic autopsy reveals complex sudden unexpected death in epilepsy risk profile. Epilepsia 55:e6-12|
|Samaco, Rodney C; McGraw, Christopher M; Ward, Christopher S et al. (2013) Female Mecp2(+/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum Mol Genet 22:96-109|
|Han, Kihoon; Holder Jr, J Lloyd; Schaaf, Christian P et al. (2013) SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503:72-7|
|Brewster, Amy L; Lugo, Joaquin N; Patil, Vinit V et al. (2013) Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PLoS One 8:e57808|
|Ali, Yousuf O; Li-Kroeger, David; Bellen, Hugo J et al. (2013) NMNATs, evolutionarily conserved neuronal maintenance factors. Trends Neurosci 36:632-40|
|Samaco, Rodney C; Mandel-Brehm, Caleigh; McGraw, Christopher M et al. (2012) Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat Genet 44:206-11|
|Lu, Nan; Shen, Qian; Mahoney, Timothy R et al. (2012) Two PI 3-kinases and one PI 3-phosphatase together establish the cyclic waves of phagosomal PtdIns(3)P critical for the degradation of apoptotic cells. PLoS Biol 10:e1001245|
Showing the most recent 10 out of 27 publications